Overview
March 10-11: Primer
March 16: Short Course
March 17: Short Course
March 18: Short Course
March 21-23: Forum
DIA is offering both a live in-person and a live-stream virtual option for the Medical Affairs and Scientific Communications Forum. Upon registration, please indicate via the check box which avenue you are registering for: in-person or virtual.
DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, by medical affairs professionals. This forum provides a comprehensive understanding of the regulatory and compliance environment directly affecting the daily activities of medical affairs and scientific communication professionals. Made up of multiple general and breakouts sessions within three tracks covering medical communications, medical writing, and medical science liaisons, you can pick and choose which sessions to attend and create your own unique forum.
Social distancing measures may be in place at the time of the event. Therefore, we encourage you to register and make your housing arrangements early due to potential limited capacity. If the capacity limit is reached, we will only be able to offer the virtual option. Don’t miss out on your chance to meet live again with your friends and colleagues!
We are thrilled to able to offer flexibility to our attendees to attend in-person or virtually. Please note, we are also offering that flexibility to our speakers so you will experience some speakers presenting remotely.
Featured
Want to learn more about Medical Affairs and Scientific Communications Forum? You've come to the right site!
Program Committee
-
Dannis Chang, PharmD Director, Hematology Medical Information Team Lead
Genentech, Inc., United States -
Amy Van Sant, PharmD, MBA President, Medical Affairs
Inizio Engage, United States -
David Meats Director, Regulatory Services & Medical Affairs Management
Certara, United States -
J. Lynn Bass, PharmD, RPh Medical Affairs Lead
Mesoblast, United States -
Ruggero Galici, PhD Director, Nonclinical and Clinical Pharmacology Writing
Alexion Pharmaceuticals, AstraZeneca Rare Disease, United States -
Hanady Elhadidy, PharmD Senior Director, Global Customer Engagement
Bristol Myers Squibb, United States -
Michelle Kissner, PharmD, RPh Director, Publications Management
Pfizer Inc, United States -
Marie-Ange Noue, PhD Senior Director, Head of Scientific Communications
EMD Serono, Canada -
Sonia Sandhu, PharmD Senior Director, Medical Information
Gilead Sciences, Inc., United States -
Robert Tamburri, PharmD, MBA Director, Medical Information
Johnson & Johnson, United States -
Diane Cleverley, PhD Associate Principal Regulatory Writer
Certara, United States -
Jennie G Jacobson, PhD President
Jacobson Medical Writing, Inc., United States -
Meera Kodukulla, PhD Senior Director, Scientific Publications
AstraZeneca, United States -
Andrea Tuttle Meyers Senior Vice President, Clinical Operations
Syneos Health, United States -
Donna Booth, PharmD Head, Field Medical Accounts-East, US Medical Affairs
GlaxoSmithKline, United States -
Danielle Day, PhD Senior Medical Director, Immunology, Rare Disease
Sobi, United States -
Sonja Hokett, PharmD, MS, MSc Executive Director, Medical Managed Care & HEOR
BioXcel Therapeutics, United States -
Paul Minne, PharmD, RPh Senior Director, MSL Team
Neurocrine Biosciences, United States -
Kay Uttech, PharmD, MA, RPh VP, Strategic Initiatives
Indegene, United States
Have an account?